Edrophonium
Back to searchMolecule Structure
Scientific Name
Edrophonium
Description of the Drug
Edrophonium is a cholinesterase inhibitor used to diagnose and evaluate myasthenia gravis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01010
http://www.drugbank.ca/drugs/DB01010
Brand Name(s)
Not Available
Company Owner(s)
Watson Laboratories Inc, Pai Holdings Llc Dba Pharmaceutical Associates Inc, Hospira Worldwide, Inc, Mylan Institutional Llc A Viatris Co, Organon Usa Inc, Mylan Institutional Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Acetylcholinesterase | SINGLE PROTEIN | INHIBITOR | CHEMBL220 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34790 | ||||
PharmGKB | PA449437 | ||||
Human Metabolome Database | HMDB0015145 | ||||
DrugBank | DB01010 | ||||
PubChem | 3202 | ||||
Mcule | MCULE-5963849469 | ||||
LINCS | LSM-5867 | ||||
Nikkaji | J5.502F | ||||
PDBe | EDR | ||||
BindingDB | 120262 | ||||
EPA CompTox Dashboard | DTXSID4046943 | ||||
DrugCentral | 988 | ||||
Brenda | 5271 | ||||
Guide to Pharmacology | 9073 | ||||
rxnorm | EDROPHONIUM | EDROPHONIUM CATION | ENLON | EDROPHONIUM CHLORIDE | ENLON-PLUS |
KEGG Ligand | C06976 | ||||
ChEBI | 251408 | ||||
ZINC | ZINC000000001341 |